News and updates
Recruitment for the SWEET study is now closed. Thanks to the amazing response we’ve successfully reached over our recruitment target.
The Study is now in the follow-up stage, to find out more click here to read our latest newsletter.
Recent presentations
Dr Lucy McGeagh with the SWEET poster at The UK Interdisciplinary Breast Cancer Symposium in January 2026.
Dr Jo Brett presenting at International Psycho-Oncology Society Annual World Congress in November 2025.
.jpg)
Lesley Turner presenting at the MASCC 2024 Annual Meeting in June.
The SWEET team have presented at the following recent conferences. In September we will be presenting at the RCN International Nursing Research Conference in Glasgow.
| Year | Conference | Presentation Title |
|---|---|---|
| 2026 | Association of Breast Cancer (ABS) | Supporting adherence to endocrine therapy- healthcare professionals' views on potential for implementation of the HT&Me intervention (poster) |
| 2026 | European Breast Cancer Conference (EBCC) | Improving treatment adherence through better side effect management (Presentation) Developing composite measures of medication adherence Combining self-report and pharmacy data in women with breast cancer prescribed adjuvant endocrine therapy (Oral poster) |
| 2026 | British Psychosocial Oncology Society Conference (BPOS) | Supporting women with breast cancer with adherence to adjuvant endocrine therapy. (Oral poster) |
| 2026 | Irish Association for Cancer Research Annual Meeting (IACR) | Supporting adherence to endocrine therapy in breast cancer - the HT&Me intervention |
| 2026 | The UK Interdisciplinary Breast Cancer Symposium (UKIBCS) | Supporting adherence to endocrine therapy - Health Care Professionals' views on the HT&Me intervention and potential for implementation |
| 2025 | IPOS World Congress of Psycho-Oncology and Psychosocial Academy (IPOS) | Supporting women with breast cancer with adherence to adjuvant endocrine therapy (SWEET) a feasibility study of the HT&Me intervention |
| 2025 | Royal College of Nursing (RCN) Conference | Supporting women with breast cancer with adherence to adjuvant endocrine therapy (SWEET) a feasibility study of the HT&Me intervention |
| 2025 | Beaumont RCSI Cancer Conference | Supporting women with breast cancer with adherence to adjuvant endocrine therapy (SWEET) a feasibility study of the HT&Me intervention |
| 2025 | Cancer in Primary Care Research International Conference (CA-PRI) | Assessing medication adherence through primary care prescribing vs pharmacy encashment data - Experiences from the SWEET feasibility study |
| 2025 | British Psychosocial Oncology Society (BPOS) | Supporting women with breast cancer with adherence to adjuvant endocrine therapy (SWEET) a feasibility study of the HT&Me intervention |
| Year | Conference | Presentation Title |
|---|---|---|
| 2024 | Multinational Association of Supportive Care in Cancer, the Association Francophone des Soins Oncologiques de Support, and the International Society of Oral Oncology) Annual Meeting (MASCC/AFSO/ISOO) | Supporting women with breast cancer with adherence to adjuvant endocrine therapy – results from the feasibility study of the HT&Me intervention |
| 2024 | Association of Breast Surgery (ABS) | Supporting women with adherence to adjuvant endocrine therapy – results from the SWEET feasibility study |
| 2024 | The UK Interdisciplinary of Breast Cancer Symposium (UKIBCS) | Developing and feasibility testing of an intervention to support women with adherence to adjuvant endocrine therapy and improve quality of life - the SWEET study |
| 2023 | International Psycho-oncology Society (IPOS) World Congress of Psycho-Oncology | Development of HT&Me, a blended supported self-management intervention to support adherence to endocrine therapy in women with breast cancer |
| 2023 | International Conference on Cancer Nursing | Developing and feasibility testing a self-management endocrine therapy adherence intervention |
| 2023 | UK Oncology Nursing Society Conference | The development and feasibility of a nurse-supported self-management intervention for endocrine therapy adherence |
| 2023 | Cancer and Primary Care Research International Network (Ca-PRI) Conference | Development of the HT&Me intervention to support women with breast cancer to adhere to adjuvant endocrine therapy and improve quality of life |
| 2023 | UCL Cancer Symposium | Supporting women with breast cancer to adhere to adjuvant endocrine therapy: development and optimisation of the HT&Me web-app |
| 2022 | Association of Breast Surgery (ABS) | Supporting women with adherence to endocrine therapy |
| 2022 | UK Interdisciplinary of Breast Cancer Symposium (UKIBCS) | Supporting women with adherence to endocrine therapy following breast cancer: the SWEET Programme |
| 2022 | British Psychological Society (BPS) Division of Health Psychology (DHP) Annual Conference | Exploring the acceptability and usefulness of a digital intervention to support adherence to adjuvant endocrine therapy (AET) in women with breast cancer |
| 2022 | British Psychosocial Oncology Society (BPOS) | Developing and optimising the HT&Me website to support adherence to adjuvant endocrine therapy (AET) in women with breast cancer |
| 2022 | UK Society for Behavioural Medicine (UKBSM) | Supporting women with breast cancer to adhere to hormone therapy: development and optimisation of the HT&Me web-app |
| 2021 | UKONS - Virtual Annual Conference | Improving outcomes for women diagnosed with early breast cancer through adherence to adjuvant endocrine therapy (SWEET): Developing a digitally based intervention |
| 2021 | Multinational Association of Supportive Care in Cancer Annual Meeting (MASCC) | Improving outcomes for women diagnosed with early breast cancer through adherence to adjuvant endocrine therapy (SWEET) |
| 2021 | International Psycho-oncology Society (IPOS) World Congress of Psycho-Oncology (Virtual) | Improving outcomes for women diagnosed with early breast cancer through adherence to adjuvant endocrine therapy (SWEET) |
| 2021 | Symposium Mammographicum | Supporting women with adherence to adjuvant endocrine therapy following breast cancer (SWEET) |
| 2020 | National Cancer Research Institute (NCRI) Conference | Supporting women with adherence to adjuvant endocrine therapy following breast cancer (SWEET) |
| 2020 | UK Interdisciplinary of Breast Cancer Symposium (UKIBCS) | Improving outcomes for women diagnosed with early breast cancer through adherence to adjuvant endocrine therapy (SWEET) |